Literature DB >> 29432063

Approach to Pulmonary Hypertension: From CT to Clinical Diagnosis.

Felipe Aluja Jaramillo1, Fernando R Gutierrez1, Federico G Díaz Telli1, Sebastian Yevenes Aravena1, Cylen Javidan-Nejad1, Sanjeev Bhalla1.   

Abstract

Pulmonary hypertension (PH) is a condition characterized by increased pressure in the pulmonary circulation. It may be idiopathic or arise in the setting of other clinical conditions. Patients with PH tend to present with nonspecific cardiovascular or respiratory symptoms. The clinical classification of PH was recently revised at the World Health Organization symposium in Nice, France, in 2013. That consensus statement provided an updated classification based on the shared hemodynamic characteristics and management of the different categories of PH. Some features seen at computed tomography (CT) can suggest a subtype or probable cause of PH that may facilitate placing the patient in the correct category. These features include findings in the pulmonary arteries (peripheral calcification, peripheral dilatation, eccentric filling defects, intra-arterial soft tissue), lung parenchyma (centrilobular nodules, mosaic attenuation, interlobular septal thickening, bronchiectasis, subpleural peripheral opacities, ground-glass opacities, diffuse nodules), heart (congenital lesions, left heart disease, valvular disease), and mediastinum (hypertrophied bronchial arteries). An approach based on identification of these CT features in patients with PH will allow the radiologist to play an important role in diagnosis and help guide the clinician in management of PH. ©RSNA, 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29432063     DOI: 10.1148/rg.2018170046

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  14 in total

1.  Pulmonary vasculitis mimicking chronic thromboembolic disease.

Authors:  Noor Ali; Lynsey Clarke; Robert Valentine MacKenzie Ross; Graham Robinson
Journal:  BMJ Case Rep       Date:  2019-04-08

Review 2.  Imaging of Chronic Thromboembolic Disease.

Authors:  Adina Haramati; Linda B Haramati
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

3.  Pulmonary capillary hemangiomatosis: a case series and review of literature.

Authors:  Mahmoud Abdelnabi; Abdallah Almaghraby; Hoda Abdelgawad; Fatma Elkafrawy; Karim Ziada
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

4.  Valved reverse Potts shunt in a case of pulmonary hypertension due to pulmonary veno-occlusive disease.

Authors:  Swati Garekar; Talha Meeran; Shyam Dhake; Dhananjay Malankar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-08-07

5.  Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.

Authors:  Qing-Qing Zhu; Tao Gong; Guo-Quan Huang; Zhong-Feng Niu; Ting Yue; Fang-Yi Xu; Chao Chen; Guang-Bin Wang
Journal:  Jpn J Radiol       Date:  2021-03-22       Impact factor: 2.374

Review 6.  Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.

Authors:  Zhijie Yu; Jun Xiao; Xiao Chen; Yi Ruan; Yang Chen; Xiaoyuan Zheng; Qiang Wang
Journal:  Chin Med       Date:  2022-01-15       Impact factor: 5.455

7.  Quantitative assessment the longitudinal changes of pulmonary vascular counts in chronic obstructive pulmonary disease.

Authors:  Sang Won Park; Myoung-Nam Lim; Woo Jin Kim; So Hyeon Bak
Journal:  Respir Res       Date:  2022-02-14

Review 8.  A narrative review of research advances in hypoxic pulmonary hypertension.

Authors:  Tianci Chai; Chen Qiu; Zhihong Xian; Yongzhen Lu; Yuwei Zeng; Jie Li
Journal:  Ann Transl Med       Date:  2022-02

9.  Adult-onset hypoxaemia, diffuse lung lesions, and pulmonary hypertension in cobalamin C defect: a case report.

Authors:  Qin-Hua Zhao; Wen-Hui Wu; Li-Jun Fu; Lan Wang
Journal:  Eur Heart J Case Rep       Date:  2021-06-30

10.  Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography.

Authors:  Luciano Folador; Felipe S Torres; Juliana F Zampieri; Betina C Machado; Marli M Knorst; Marcelo B Gazzana
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.